12 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
, Yescarta and Tecartus.
We believe that actively exploring and forming the right partnerships to drive innovation and enhance our pipeline is core to our … , on continuing technological innovation and on in-licensing opportunities to develop, strengthen and maintain the strength of our position in the field of cell
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which … . The consultation closed on March 14, 2022. The reframe aims to streamline clinical trials approvals, enable innovation, enhance clinical trials
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or FDIC, as receiver. Similarly, on March … trials approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public
S-1/A
hluw4sp 9m
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-10.2
lmmwqhyay klv073
12 Jun 23
IPO registration
4:28pm
S-1
EX-4.2
yfwdrkz81ji xsal
12 Jun 23
IPO registration
4:28pm
S-1
n1q0a
12 Jun 23
IPO registration
4:28pm
DRS
djndmv5zfve8pe
15 May 23
Draft registration statement
12:00am
DRS
EX-10.2
jbdl4ae0h wiztpcfvu
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next